Keigo Shibagaki
Jiyugaoka, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Relationships of high mean corpuscular volume, low total iron binding capacity and protein-energy wasting in patients on maintenance hemodialysis.
Journal: Clinical and experimental nephrology
Published: January 12, 2026
Associations of roxadustat with copper elevation and hypothyroidism in patients on hemodialysis.
Journal: International urology and nephrology
Published: July 16, 2025
Seasonal variation in predialysis systolic blood pressure and cardiovascular events in patients on maintenance hemodialysis.
Journal: Hypertension research : official journal of the Japanese Society of Hypertension
Published: February 21, 2023
Changes of biomarkers for erythropoiesis, iron metabolism, and FGF23 by supplementation with roxadustat in patients on hemodialysis.
Journal: Scientific reports
Published: December 26, 2022
Mean annual intradialytic blood pressure decline and cardiovascular events in Japanese patients on maintenance hemodialysis.
Journal: Hypertension research : official journal of the Japanese Society of Hypertension
Published: August 10, 2022
Seasonal variation and predictors of intradialytic blood pressure decline: a retrospective cohort study.
Journal: Hypertension research : official journal of the Japanese Society of Hypertension
Published: April 23, 2021
Erythropoiesis stimulating agents are associated with serum fibroblast growth factor 23 metabolism in patients on hemodialysis.
Journal: Clinical kidney journal
Published: September 04, 2019
Differential Impacts of Intravenous Iron Administration and Iron-Containing Phosphate Binders on Serum Intact Fibroblast Growth Factor 23 Levels.
Journal: Blood purification
Published: April 04, 2019
Associations among Erythroferrone and Biomarkers of Erythropoiesis and Iron Metabolism, and Treatment with Long-Term Erythropoiesis-Stimulating Agents in Patients on Hemodialysis.
Journal: PloS one
Published: December 08, 2015
Effects of Long-Term Erythropoiesis-Stimulating Agents on Iron Metabolism in Patients on Hemodialysis.
Journal: Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy
Published: October 21, 2015
Showing 1-10 of 10
Last Updated: 09/26/2026